中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

我国非酒精性脂肪性肝病的研究现状

胡中杰 张晶

引用本文:
Citation:

我国非酒精性脂肪性肝病的研究现状

DOI: 10.3969/j.issn.1001-5256.2016.03.034
详细信息
  • 中图分类号: R575.5

Current status of research on nonalcoholic fatty liver disease in China

  • 摘要: 随着非酒精性脂肪性肝病(NAFLD)患病率的不断增加,公众的重视程度得到提高,相关研究逐渐增多,也取得了一些重要的进展。介绍了近5年来,我国在NAFLD的流行病学、危险因素、发病机制、无创性诊断、治疗及相关肝硬化和肝癌等方面重要的研究成果,了解我国的研究现状。指出与国际相比,我国相关临床和基础研究还存在一定的差距,尤其在公众的认知及医务工作者的重视度等方面;未来还应加强在流行病学、发病机制、患者的管理及药物治疗等方面的研究。

     

  • [1]YANG RX,FAN JG.Current epidemic status of nonalcoholic fatty liver disease[J].J Clin Intern Med,2015,32(5):293-296.(in Chinese)杨蕊旭,范建高.非酒精性脂肪性肝病的流行现状[J].临床内科杂志,2015,32(5):293-296.
    [2]LI F,CAI XB,FAN JG,et al.Prevalence of metabolic disorders in individuals with fatty liver at different age stages[J].Chin Hepatol,2012,17(7):470-473.(in Chinese)李锋,蔡晓波,范建高,等.不同年龄层次脂肪肝患者中代谢异常发生情况分析[J].肝脏,2012,17(7):470-473.
    [3]HOU SQ,XIN YN,XUAN SY,et al.Current status of incidence of fatty liver disease and its influencing factors in populations living in coastal regions:a preliminary study based on physical examination records[J].Chin J Hosp Stat,2013,20(3):199-201.(in Chinese)侯素青,辛永宁,宣世英,等.基于体检档案对沿海地区人群脂肪性肝病发病现状及影响因素初探[J].中国医院统计,2013,20(3):199-201.
    [4]LI JP,DING YY,WANG BY,et al.Epidemiological survey of prevalence of fatty liver disease and its risk factors in urban population of northeast China[J].2011,20(7):617-620,623.(in Chinese)李金萍,丁媛媛,王炳元,等.东北地区城市脂肪肝的患病率及其危险因素的流行病学调查[J].胃肠病学和肝病学杂志,2011,20(7):617-620,623.
    [5]HE S,BAO W,SHAO M,et al.Risk factors for non-alcoholic fatty liver disease in a Chinese population[J].Acta Gastroenterol Belg,2011,74(4):503-508.
    [6]XIANG GQ,MENG XD,WANG BY,et al.Prevalence of fatty liver among people with different occupation in Shenyang[J].J Clin Hepatol,2010,26(3):283-285.(in Chinese)向国卿,孟晓丹,王炳元,等.沈阳市不同职业人群脂肪肝的流行现状分析[J].临床肝胆病杂志,2010,26(3):283-285.
    [7]ZHANG ZG,XUE L,ZHANG YX,et al.Analysis of the prevalence of nonalcoholic fatty liver disease in uygur civil servants in Urumqi[J].Modern Prevent Med,2012,39(8):1955-1957.(in Chinese)张泽高,薛黎,张跃新,等.乌鲁木齐市公务员非酒精性脂肪肝调查[J].现代预防医学,2012,39(8):1955-1957.
    [8]FAN JG,ZHOU Q,WO QH,et al.Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease[J].Chin J Hepatol,2010,18(9):676-679.(in Chinese)范建高,周琪,沃千红,等.人体质量指数及其变化与非酒精性脂肪性肝病发病的关系[J].中华肝脏病杂志,2010,18(9):676-679.
    [9]XU C,YU C,MA H,et al.Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population:the Zhejiang Zhenhai Study[J].Am J Gastroenterol,2013,108(8):1299-1304.
    [10]ZHOU X,HOU DQ,DUAN JL,et al.Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing,China[J].Chin J Epidemiol,2013,34(5):446-450.(in Chinese)周歆,侯冬青,段佳丽,等.北京市387名肥胖中学生非酒精性脂肪肝等代谢异常罹患状况调查[J].中华流行病学杂志,2013,34(5):446-450.
    [11]SU L,LIU YL.Risk factors for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus[J].Chin J Gen Prac,2010,9(1):47-49.(in Chinese)苏琳,刘玉兰.2型糖尿病患者合并非酒精性脂肪性肝病危险因素分析[J].中华全科医师杂志,2010,9(1):47-49.
    [12]HU CB,SHI JP.The relationship between fatty liver and hyperuricemia[J].Chin Hepatol,2011,16(3):202-205.(in Chinese)胡晨波,施军平.脂肪肝与高尿酸血症关系的探讨[J].肝脏,2011,16(3):202-205.
    [13]XU C,YU C,XU L,et al.High serum uric acid increases the risk for nonalcoholic fatty liver disease:a prospective observational study[J].PLo S One,2010,5(7):e11578.
    [14]XU C,WAN X,XU L,et al.Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia:one stone hits two birds[J].J Hepatol,2015,62(6):1412-1419.
    [15]IHARA Y,YOSHIMURA M,MIYOSHI E,et al.Ectopic expression of N-acetylglucosaminyltransferaseⅢin transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage[J].Proc Natl Acad Sci U S A,1998,95(5):2526-2530.
    [16]FU J,GERHARDT H,MCDANIEL JM,et al.Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice[J].J Clin Invest,2008,118(11):3725-3737.
    [17]ZHAN Y,ZHAO F,XIE P,et al.Mechanism of the effect of glycosyltransferase GLT8D2 on fatty liver[J].Lipids Health Dis,2015,14:43.
    [18]XU J,XIN YN,LYU WH,et al.Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease[J].Chin J Hepatol,2013,21(8):619-623.(in Chinese)徐静,辛永宁,吕维红,等.PNPLA3 rs738409基因多态性与非酒精性脂肪性肝病遗传易感性的关系[J].中华肝脏病杂志,2013,21(8):619-623.
    [19]ZHANG Y,CAI W,SONG J,et al.Association between the PNPLA3 I148M polymorphism and non-alcoholic fatty liver disease in the Uygur and Han ethnic groups of northwestern China[J].PLo S One,2014,9(10):e108381.
    [20]ZHANG H,CHEN L,XIN Y,et al.Apolipoprotein c3 gene polymorphisms are not a risk factor for developing non-alcoholic Fatty liver disease:a meta-analysis[J].Hepat Mon,2014,14(10):e23100.
    [21]SHEN F,ZHENG RD,MI YQ.A multi-center clinical study of a novel controlled attenuation parameter for assessment of fatty liver[J].Chin J Hepatol,2014,22(12):926-931.(in Chinese)沈峰,郑瑞丹,宓余强,等.受控衰减参数诊断脂肪肝的临界值初探:一项多中心临床研究[J].中华肝脏病杂志,2014,22(12):926-931.
    [22]SHEN F,XU ZJ,PAN Q,et al.Influencing factors and reproducibility of controlled attenuation parameters in the evaluation of fatty liver disease using Fibro Scan[J].J Pract Hepatol,2013,16(1):59-62.(in Chinese)沈峰,徐正婕,潘勤,等.Fibro Scan R实施受控衰减参数评价脂肪肝的影响因素及重复性分析[J].实用肝脏病杂志,2013,16(1):59-62.
    [23]ZHU MF,LIU J,WANG J,et al.Effection of HBV on controlled attenuation parameters using Fibro Scan(R)[J].Chin J Exp Clin Virol,2014,28(1):7-9.(in Chinese)朱梦飞,刘静,王洁,等.HBV感染对Fibro Scan(R)实施受控衰减参数评价脂肪肝影响的研究[J].中华实验和临床病毒学杂志,2014,28(1):7-9.
    [24]LI H,WANG L,YAN X,et al.A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease[J].J Proteome Res,2011,10(6):2797-2806.
    [25]CAO W,ZHAO C,SHEN C,et al.Cytokeratin 18,alanine aminotransferase,platelets and triglycerides predict the presence of nonalcoholic steatohepatitis[J].PLo S One,2013,8(12):e82092.
    [26]Group of Fatty Liver and Alcoholic Liver Diseases,Society of Hepatology,Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].J Clin Hepatol,2010,26(2):120-124.(in Chinese)中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].临床肝胆病杂志,2010,26(2):120-124.
    [27]CHALASANI N,YOUNOSSI Z,LAVINE JE,et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Association for the Study of Liver Disease,American College of Gastroenterology,and the American Gastroenterological Association[J].Hepatology,2012,55(6):2005-2023.
    [28]FAN JG,FARRELL GC.Epidemiology of non-alcoholic fatty liver disease in China[J].J Hepatol,2009,50(11):204-210.
    [29]LI L,DING HG.Clinical features of cirrhosis due to nonalcoholic steatohepatitis[J].J Clin Hepatol,2011,27(10):1032-1035.(in Chinese)李磊,丁惠国.20例非酒精性脂肪性肝硬化的临床特征分析[J].临床肝胆病杂志,2011,27(10):1032-1035.
    [30]ASCHA MS,HANOUNEH IA,LOPEZ R,et al.The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis[J].Hepatology,2010,51(6):1972-1978.
    [31]LIU J,JIN X,YU CH,et al.Endoplasmic reticulum stress involved in the course of lipogenesis in fatty acids-induced hepatic steatosis[J].J Gastroenterol Hepatol,2010,25(3):613-618.
    [32]CHEN WT,ZHU G,PFAFFENBAEH K,et al.GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN[J].Oncogene,2014,33(42):4997-5005.
    [33]ZHENG L,YANG W,WU F,et al.Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma[J].Clin Cancer Res,2013,19(19):5372-5380.
    [34]QU KZ,ZHANG K,LI H,et al.Circulating microRNAs as biomarkers for hepatocellular carcinoma[J].J Clin Gastroenterol,2011,45(4):355-360.
    [35]FAN JG,ZHUANG H,HUANG Y,et al.Key words in the first“popular science edition”of guidelines for the prevention and treatment of fatty liver disease[J].Liver Doct,2015,(3):14-18.(in Chinese)范建高,庄辉,黄薏,等.全球首部“科普版”《脂肪肝防治指南》[J].肝博士,2015,(3):14-18.
    [36]ZENG MD,WANG BY,CHEN CW,et al.General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease[J].Chin J Hepatol,2011,19(5):362-366.(in Chinese)曾民德,王炳元,陈成伟,等.非酒精性脂肪性肝病患者基本特征及诊疗规范的调查研究[J].中华肝脏病杂志,2011,19(5):362-366.
    [37]Group of Fatty Liver and Alcoholic Liver Diseases,Society of Hepatology,Chinese Medical Association.Guidelines for management of non-alcoholic fatty liver disease[J].Chin Hepatol,2006,11(1):68-70.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].肝脏,2006,11(1):68-70.
  • 加载中
计量
  • 文章访问数:  2551
  • HTML全文浏览量:  59
  • PDF下载量:  532
  • 被引次数: 0
出版历程
  • 出版日期:  2016-03-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回